Neuroscience Trials Australia
- Country
- 🇦🇺Australia
- Ownership
- Private
- Established
- 2001-01-01
- Employees
- 51
- Market Cap
- -
Clinical Trials
12
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials
DIRECT-SAFE: A Randomized Controlled Trial of DIRECT Endovascular Clot Retrieval Versus Standard Bridging Thrombolysis With Endovascular Clot Retrieval
- Conditions
- Ischemic Stroke
- First Posted Date
- 2018-04-11
- Last Posted Date
- 2022-06-16
- Lead Sponsor
- Neuroscience Trials Australia
- Target Recruit Count
- 295
- Registration Number
- NCT03494920
- Locations
- 🇦🇺
Liverpool Hospital, Liverpool, New South Wales, Australia
🇦🇺John Hunter Hospital, New Lambton, New South Wales, Australia
🇦🇺Royal North Shore Hospital, St Leonards, New South Wales, Australia
STOP-MSU: Stopping Haemorrhage With Tranexamic Acid for Hyperacute Onset Presentation Including Mobile Stroke Units
- Conditions
- Intracerebral Haemorrhage
- Interventions
- Drug: Normal saline
- First Posted Date
- 2017-12-29
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- Neuroscience Trials Australia
- Target Recruit Count
- 201
- Registration Number
- NCT03385928
- Locations
- 🇦🇺
Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
🇦🇺Liverpool Hospital, Liverpool, New South Wales, Australia
🇦🇺John Hunter Hospital, New Lambton Heights, New South Wales, Australia
Determining the Optimal Dose of Tenecteplase Before Endovascular Therapy for Ischaemic Stroke (EXTEND-IA TNK Part 2)
- First Posted Date
- 2017-11-13
- Last Posted Date
- 2020-03-04
- Lead Sponsor
- Neuroscience Trials Australia
- Target Recruit Count
- 300
- Registration Number
- NCT03340493
- Locations
- 🇦🇺
Albury Hospital, Albury, New South Wales, Australia
🇦🇺Bankstown-Lidcombe Hospital, Bankstown, New South Wales, Australia
🇦🇺Campbelltown Hospital, Campbelltown, New South Wales, Australia
Trial of EXenatide in Acute Ischaemic Stroke
- First Posted Date
- 2017-09-19
- Last Posted Date
- 2021-09-14
- Lead Sponsor
- Neuroscience Trials Australia
- Target Recruit Count
- 350
- Registration Number
- NCT03287076
- Locations
- 🇦🇺
St Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia
🇦🇺Liverpool Hospital, Liverpool, New South Wales, Australia
🇦🇺Sunshine Coast University Hospital, Birtinya, Queensland, Australia
Deferiprone to Delay Dementia (The 3D Study)
- Conditions
- Mild Cognitive ImpairmentProdromal Alzheimer's DiseaseMild Alzheimer's Disease
- Interventions
- Drug: Placebo Oral Tablet
- First Posted Date
- 2017-07-31
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Neuroscience Trials Australia
- Target Recruit Count
- 81
- Registration Number
- NCT03234686
- Locations
- 🇦🇺
KaRa Institute of Neurological Diseases, Macquarie Park, New South Wales, Australia
🇦🇺Hunter New England Local Health District, Waratah, New South Wales, Australia
🇦🇺Box Hill Hospital, Box Hill, Victoria, Australia
- Prev
- 1
- 2
- 3
- Next